Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PDC*lung01 |
Trade Name | |
Synonyms | PDClung01|Therapeutic Cancer Vaccine PDC*lung01 |
Drug Descriptions |
PDC*lung01 is a cancer vaccine comprising plasmacytoid dendritic cells armed with seven lung tumor antigen-derived peptides, which may result in priming and expansion of CD8-positive T cells, potentially inducing an anti-tumor immune response (Annals of Oncology 33 (2022): S1086). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C173427 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
PDC*lung01 | PDC*lung01 | 0 | 1 |
PDC*lung01 + Pembrolizumab | PDC*lung01 Pembrolizumab | 0 | 1 |
PDC*lung01 + Pemetrexed Disodium | PDC*lung01 Pemetrexed Disodium | 0 | 1 |